Rapid rebound of the treg compartment in DEREG mice limits the impact of treg depletion on mycobacterial burden, but prevents autoimmunity

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Berod, Luciana ^a   Stüve, Philipp ^a   Varela, Filipa ^b   Behrends, Jochen ^b   Swallow, Maxine ^a   Kruse, Friederike ^a   Krull, Freyja ^a   Ghorbani, Peyman ^a   Mayer, Christian T ^a   Hölscher, Christoph ^b,c   Sparwasser, Tim ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b RESEARCH CENTER BORSTEL   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TOXIN; ENHANCED GREEN FLUORESCENT PROTEIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; TRANSCRIPTION FACTOR FOXP3; AUTACOID; CYTOKINE; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; GREEN FLUORESCENT PROTEIN; HEPARIN BINDING EPIDERMAL GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; BACTERIAL LOAD; BOVINE TUBERCULOSIS; CD4+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; INFLAMMATION; LYMPHOCYTE DEPLETION; MOUSE; MYCOBACTERIUM BOVIS BCG; NONHUMAN; REGULATORY T LYMPHOCYTE; RISK FACTOR; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; FLOW CYTOMETRY; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LUNG TUBERCULOSIS; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; PHYSIOLOGY; PROCEDURES; TRANSGENIC MOUSE; TUBERCULOSIS;

ANIMALS; AUTOIMMUNITY; BACTERIAL LOAD; CYTOKINES; FLOW CYTOMETRY; FORKHEAD TRANSCRIPTION FACTORS; GREEN FLUORESCENT PROTEINS; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR; HOST-PATHOGEN INTERACTIONS; INFLAMMATION MEDIATORS; LYMPHOCYTE DEPLETION; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES, REGULATORY; TUBERCULOSIS; TUBERCULOSIS, PULMONARY;

EID: 84904694614     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102804     Document Type: Article

References (61)

1. Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008) Regulatory T cells and immune tolerance. Cell 133: 775-787. (Pubitemid 351707693)
2. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, et al. (2006) Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 212: 8-27. (Pubitemid 44116697)
3. Belkaid Y (2008) Role of Foxp3-positive regulatory T cells during infection. Eur J Immunol 38: 918-921.
4. Belkaid Y, Tarbell K (2009) Regulatory T cells in the control of host-microorganism interactions. Annu Rev Immunol 27: 551-589.
5. Berod L, Puttur F, Huehn J, Sparwasser T (2012) Tregs in infection and vaccinology: heroes or traitors? Microb Biotechnol 5: 260-269.
6. Dietze KK, Zelinskyy G, Gibbert K, Schimmer S, Francois S, et al. (2011) Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points. Proc Natl Acad Sci U S A 108: 2420-2425.
7. van Maren WW, Jacobs JF, de Vries IJ, Nierkens S, Adema GJ (2008) Toll-like receptor signalling on Tregs: to suppress or not to suppress? Immunology 124: 445-452.
8. Wohlfert E, Belkaid Y (2010) Plasticity of T reg at infected sites. Mucosal Immunol 3: 213-215.
9. Scott-Browne JP, Shafiani S, Tucker-Heard G, Ishida-Tsubota K, Fontenot JD, et al. (2007) Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J Exp Med 204: 2159-2169. (Pubitemid 47360876)
10. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A (2006) Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 173: 803-810.
11. Chen X, Zhou B, Li M, Deng Q, Wu X, et al. (2007) CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease. Clin Immunol 123: 50-59. (Pubitemid 46420558)
12. Hougardy JM, Verscheure V, Locht C, Mascart F (2007) In vitro expansion of CD4+CD25highFOXP3+CD127low/- regulatory T cells from peripheral blood lymphocytes of healthy Mycobacterium tuberculosis-infected humans. Microbes Infect 9: 1325-1332. (Pubitemid 47539207)
13. McBride A, Konowich J, Salgame P (2013) Host defense and recruitment of Foxp3(+) T regulatory cells to the lungs in chronic Mycobacterium tuberculosis infection requires toll-like receptor 2. PLoS Pathog 9(6): e1003397.
14. Ordway DJ, Shang S, Henao-Tamayo M, Obregon-Henao A, Nold L, et al. (2011) Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells. Clin Vaccine Immunol 18: 1527-1535.
15. Jaron B, Maranghi E, Leclerc C, Majlessi L (2008) Effect of attenuation of Treg during BCG immunization on anti-mycobacterial Th1 responses and protection against Mycobacterium tuberculosis. PLoS One 3(7): e2833.
16. Ho P, Wei X, Seah GT (2010) Regulatory T cells induced by Mycobacterium chelonae sensitization influence murine responses to bacille Calmette-Guerin. J Leukoc Biol 88: 1073-1080.
17. Wammes LJ, Hamid F, Wiria AE, de Gier B, Sartono E, et al. (2010) Regulatory T cells in human geohelminth infection suppress immune responses to BCG and Plasmodium falciparum. Eur J Immunol 40: 437-442.
18. Fontenot JD, Gavin MA, Rudensky AY (2003) Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol 4: 330-336. (Pubitemid 36432314)
19. Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061. (Pubitemid 36222930)
20. Khattri R, Cox T, Yasayko SA, Ramsdell F (2003) An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol 4: 337-342. (Pubitemid 36432315)
21. Quinn KM, McHugh RS, Rich FJ, Goldsack LM, de Lisle GW, et al. (2006) Inactivation of CD4 + CD25+ regulatory T cells during early mycobacterial infection increases cytokine production but does not affect pathogen load. Immunol Cell Biol 84: 467-474. (Pubitemid 44286041)
22. Ozeki Y, Sugawara I, Udagawa T, Aoki T, Osada-Oka M, et al. (2010) Transient role of CD4+CD25+ regulatory T cells in mycobacterial infection in mice. Int Immunol 22: 179-189.
23. Kursar M, Koch M, Mittrucker HW, Nouailles G, Bonhagen K, et al. (2007) Cutting Edge: Regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J Immunol 178: 2661-2665. (Pubitemid 46333142)
24. Pace L, Tempez A, Arnold-Schrauf C, Lemaitre F, Bousso P, et al. (2012) Regulatory T cells increase the avidity of primary CD8+ T cell responses and promote memory. Science 338: 532-536.
25. Kastenmuller W, Gasteiger G, Subramanian N, Sparwasser T, Busch DH, et al. (2011) Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction. J Immunol 187: 3186-3197.
26. Lahl K, Loddenkemper C, Drouin C, Freyer J, Arnason J, et al. (2007) Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J Exp Med 204: 57-63. (Pubitemid 46148756)
27. Lahl K, Sparwasser T (2011) In vivo depletion of FoxP3+ Tregs using the DEREG mouse model. Methods Mol Biol 707: 157-172.
28. Kim J, Lahl K, Hori S, Loddenkemper C, Chaudhry A, et al. (2009) Cutting edge: depletion of Foxp3+ cells leads to induction of autoimmunity by specific ablation of regulatory T cells in genetically targeted mice. J Immunol 183: 7631-7634.
29. Kim JM, Rasmussen JP, Rudensky AY (2007) Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol 8: 191-197. (Pubitemid 46152650)
30. Suffner J, Hochweller K, Kuhnle MC, Li X, Kroczek RA, et al. (2010) Dendritic cells support homeostatic expansion of Foxp3+ regulatory T cells in Foxp3.LuciDTR mice. J Immunol 184: 1810-1820.
31. Fernandez MA, Yu U, Zhang G, White R, Sparwasser T, et al. (2013) Treg depletion attenuates the severity of skin disease from ganglionic spread after HSV-2 flank infection. Virology 447: 9-20.
32. Abel S, Luckheide N, Westendorf AM, Geffers R, Roers A, et al. (2012) Strong impact of CD4+ Foxp3+ regulatory T cells and limited effect of T cell-derived IL-10 on pathogen clearance during Plasmodium yoelii infection. J Immunol 188: 5467-5477.
33. Reuter D, Sparwasser T, Hunig T, Schneider-Schaulies J (2012) Foxp3+ regulatory T cells control persistence of viral CNS infection. PLoS One 7(3): e33989.
34. Oldenhove G, Bouladoux N, Wohlfert EA, Hall JA, Chou D, et al. (2009) Decrease of Foxp3 + Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 31: 772-786.
35. Shafiani S, Tucker-Heard G, Kariyone A, Takatsu K, Urdahl KB (2010) Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J Exp Med 207: 1409-1420.
36. Shafiani S, Dinh C, Ertelt JM, Moguche AO, Siddiqui I, et al. (2013) Pathogen-Specific Treg Cells Expand Early during Mycobacterium tuberculosis Infection but Are Later Eliminated in Response to Interleukin-12. Immunity 38: 1261-1270.
37. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, et al. (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178: 2249-2254. (Pubitemid 23344886)
38. Green AM, Difazio R, Flynn JL (2013) IFN-gamma from CD4 T cells is essential for host survival and enhances CD8 T cell function during Mycobacterium tuberculosis infection. J Immunol 190: 270-277.
39. Rausch S, Huehn J, Loddenkemper C, Hepworth MR, Klotz C, et al. (2009) Establishment of nematode infection despite increased Th2 responses and immunopathology after selective depletion of Foxp3+ cells. Eur J Immunol 39: 3066-3077.
40. Thornton AM, Korty PE, Tran DQ, Wohlfert EA, Murray PE, et al. (2010) Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells. J Immunol 184: 3433-3441.
41. Yadav M, Louvet C, Davini D, Gardner JM, Martinez-Llordella M, et al. (2012) Neuropilin-1 distinguishes natural and inducible regulatory T cells among regulatory T cell subsets in vivo. J Exp Med. 209: 1713-1722, S1711-1719.
42. Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, et al. (2005) Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341. (Pubitemid 40387475)
43. Darce J, Rudra D, Li L, Nishio J, Cipolletta D, et al. (2012) An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes. Immunity 36: 731-741.
44. Bettini ML, Pan F, Bettini M, Finkelstein D, Rehg JE, et al. (2012) Loss of epigenetic modification driven by the Foxp3 transcription factor leads to regulatory T cell insufficiency. Immunity 36: 717-730.
45. Mayer CT, Ghorbani P, Kühl AA, Stüve P, Hegemann M, et al. (2014) Few Foxp3+ regulatory T cells are sufficient to protect adult mice from lethal autoimmunity. Eur J Immunol: In press.
46. Lehmann J, Huehn J, de la Rosa M, Maszyna F, Kretschmer U, et al. (2002) Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc Natl Acad Sci U S A 99: 13031-13036.
47. Miyara M, Sakaguchi S (2007) Natural regulatory T cells: mechanisms of suppression. Trends Mol Med 13: 108-116. (Pubitemid 46341958)
48. Vignali DA, Collison LW, Workman CJ (2008) How regulatory T cells work. Nat Rev Immunol 8: 523-532.
49. Wilczynski JR, Radwan M, Kalinka J (2008) The characterization and role of regulatory T cells in immune reactions. Front Biosci 13: 2266-2274. (Pubitemid 351589251)
50. Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, et al. (2008) CTLA-4 control over Foxp3+ regulatory T cell function. Science 322: 271-275.
51. Bold TD, Ernst JD (2012) CD4+ T cell-dependent IFN-gamma production by CD8+ effector T cells in Mycobacterium tuberculosis infection. J Immunol 189: 2530-2536.
52. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A (2001) Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 19: 683-765. (Pubitemid 32368050)
53. Murray PJ, Wang L, Onufryk C, Tepper RI, Young RA (1997) T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 158: 315-321. (Pubitemid 127483871)
54. Turner J, Gonzalez-JuarreroM, Ellis DL, Basaraba RJ, Kipnis A, et al. (2002) In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol 169: 6343-6351. (Pubitemid 36903482)
55. Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, et al. (1999) Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis 180: 2069-2073.
56. Othieno C, Hirsch CS, Hamilton BD, Wilkinson K, Ellner JJ, et al. (1999) Interaction of Mycobacterium tuberculosis-induced transforming growth factor beta1 and interleukin-10. Infect Immun 67: 5730-5735. (Pubitemid 29508092)
57. Boussiotis VA, Tsai EY, Yunis EJ, Thim S, Delgado JC, et al. (2000) IL-10-producing T cells suppress immune responses in anergic tuberculosis patients. J Clin Invest 105: 1317-1325. (Pubitemid 30266085)
58. Liston A, Gray DH (2014) Homeostatic control of regulatory T cell diversity. Nat Rev Immunol 14: 154-165.
59. Sugiyama D, Nishikawa H, Maeda Y, Nishioka M, Tanemura A, et al. (2013) Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+ regulatory T cells, evoking antitumor immune responses in humans. Proc Natl Acad Sci U S A 110: 17945-17950.
60. Marabelle A, Kohrt H, Levy R (2013) Intratumoral anti-CTLA-4 therapy: enhancing efficacy while avoiding toxicity. Clin Cancer Res 19: 5261-5263.
61. Zal T, Volkmann A, Stockinger B (1994) Mechanisms of tolerance induction in major histocompatibility complex class II-restricted T cells specific for a bloodborne self-antigen. J Exp Med 180: 2089-2099. (Pubitemid 24351590)